Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: Emergency department screening and acute stroke service treatment

New Zealand Medical Journal

Volumn 118, Issue 1214, 2005, Pages

  Fink, John ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; RANITIDINE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DETERIORATION; EMERGENCY WARD; EXPERIENCE; FEMALE; FIBRINOLYTIC THERAPY; GENERAL CONDITION IMPROVEMENT; HEALTH SERVICE; HUMAN; MALE; MEDICAL AUDIT; NEW ZEALAND; OUTCOMES RESEARCH; PATIENT REFERRAL; PRACTICE GUIDELINE; PUBLIC HOSPITAL; SCORING SYSTEM; SCREENING; STROKE; TIME; ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED DISORDER; EMERGENCY HEALTH SERVICE; EVALUATION; HOSPITALIZATION; MIDDLE AGED;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS, PUBLIC; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEW ZEALAND; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 23844495262     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-7.
2. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283:1151-8.
3. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2003:CD000213.
4. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003;34:2847-50.
5. Adams HP, Jr., Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-74.
6. Williams LS, Yilmaz EY, Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke. 2000;31:858-62.
7. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.
8. Truwit CL, Barkovich AJ, Gean-Marton A, et al. Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology. 1990;176:801-6.
9. Barber PA, Zhang J, Demchuk AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015-20.
10. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-13.
11. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke. 2002;33:160-6.
12. Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003;34:71-6.
13. Kidwell CS, Starkman S, Eckstein M, et al. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke. 2000;31:71-6.
14. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997;28:2109-18.
15. Stern EB, Berman M, Thomas JJ, Klassen AC. Community education for stroke awareness: An efficacy study. Stroke. 1999;30:720-3.
16. Becker K, Fruin M, Gooding T, et al. Community-based education improves stroke knowledge. Cerebrovasc Dis. 2001;11:34-43.
17. Kwan J, Hand P, Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM. 2004;97:273-9.
18. Hack W, Kaste M, Bogousslavsky J, et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis. 2003;16:311-37.
19. Moodie ML, Carter R, Mihalopoulos C, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke. 2004;35:1041-6.
20. McNaughton H, Baskett J. Life after stroke: New Zealand guideline for management of stroke. Best practice evidence-based guideline. Wellington: Stroke Foundation of New Zealand; 2003, p84. Available online. URL: http://www.nzgg.org.nz/guidelines/ dsp_guideline_popup.cfm?&guidelineID=37 Accessed April 2005.
21. Barber PA, Anderson NE, Bennett P, Gommans J. Acute stroke services in New Zealand. N Z Med J. 2002;115:3-6.
22. Gommans J, Barber A, McNaughton H, et al. Stroke rehabilitation services in New Zealand. N Z Med J 2003;116(1174). URL: http://www.nzma.org.nz/journal/116-1174/435
23. Langhorne P, Pollock A. What are the components of effective stroke unit care? Age Ageing. 2002;31:365-71.